Intl. Biotechnology Trust PLC
22 January 2001
Letters to Company Announcements
SUBSTANTIAL SHARE INTEREST NOTIFICATION
We are writing to advise you that the Company was notified on 17 January 2001,
that following the recent Tender Offer Co-operative Insurance Society Limited
has increased its beneficial interest in the Company, and now has an interest in
8,098,967 ordinary shares of 25p each, representing 16.66% of the 48,615,467
ordinary shares in issue.
SUBSTANTIAL SHARE INTEREST NOTIFICATION
We are writing to advise you that the Company was notified on 19 January 2001,
that following the Tender Offer Rothschild Asset Management Limited has ceased
to have a beneficial interest in the issued share capital of the Company.
SUBSTANTIAL SHARE INTEREST NOTIFICATION
We are writing to advise you that the Company was notified on 16 January 2001,
that following the recent Tender Offer AXA Investment Managers UK Limited has
decreased its beneficial interest in the Company, and now has an interest in
3,372,656 ordinary shares of 25p each, representing 6.94% of the 48,615,467
ordinary shares in issue.
SUBSTANTIAL SHARE INTEREST NOTIFICATION
We are writing to advise you that the Company was notified on 17 January 2001,
that following acceptance of the Company's Tender Offer, Charlamont Trading
Limited has ceased to have an interest in the issued share capital of the
Company and in consequence Quantum Partners and Quantum Endowment Fund NV have
also ceased to hold an interest in the shares.
Letters from Schroder Investment Management Ltd on behalf of
International Biotechnology Trust plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.